Watch our video about the RaniPill™ capsule.
Millions of patients with chronic conditions require biologic drugs that today can only be injected. These injections are painful and inconvenient and often affect both patient compliance and quality of life. The pharma industry has been searching for decades to convert injectables into pills, and we believe the solution is the RaniPill™ capsule. Our preclinical studies have demonstrated delivery equivalent to subcutaneous injections with several molecules, and we have completed a successful Phase I study with Octreotide.Learn More
Find Out How Our Pill Works.
The RaniPill™ capsule is swallowed by the patient and makes its way past the stomach to the intestine.
Once the RaniPill™ capsule reaches the intestine, it activates revealing the delivery mechanism.
The drug is absorbed as efficiently as a subcutaneous injection.
Octreotide can lower levels of excess growth hormone for the treatment of acromegaly.
TNF-alpha (TNFα) inhibitors suppresses response to tumor necrosis factor, part of the inflammatory response.
Commonly used for the treatment of osteoporosis and hypoparathyroidism, PTH increases the concentration of calcium in the blood.
Human Growth Hormone (HGH) is a peptide hormone that stimulates growth, cell reproduction and regeneration.
Glucagon-like peptide-1 agonists or GLP-1 mimetics are a class of drugs used in the treatment of Type II diabetes and obesity.
Basal insulin or “background insulin” is used in diabetes management as a way to regulate glucose levels in between meals.
The RaniPill™ capsule has broad applications for the treatment of NETs and acromegaly, rheumatoid arthritis, psoriatic arthritis, growth hormone deficiency, osteoporosis, Crohn’s disease, hemophilia, diabetes, among other diseases.More details